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(MMPs) which degrade the cartilage matrix. Of the cytokines implicated
in the pathophysiology of OA, IL-1 has attracted the most interest as a
target for disease modiﬁcation and IL-1 inhibition has been reported to
be beneﬁcial in several animal models of OA. In considering potential
barriers that may limit the use of biological therapeutics in treating
cartilage-associated diseases, we asked whether two IL-1 receptor
antagonists were capable of penetrating cartilage and reaching the IL-1
receptor on chondrocytes. In the present study we evaluate the efﬁcacy
of IL-1ra (Kineret; ~17 kDa) and a monoclonal IL-1R antibody (6F3;
~150 kDa)) as antagonists of IL-1 in human chondrocytes and cartilage
explants from non-arthritic donors.
Methods: Human primary chondrocytes and cartilage explants (3-
mm diameter) were obtained from Articular Engineering (Chicago, IL).
Chondrocytes and cartilage explants were incubated with Kineret or
6F3 for 30 min prior to stimulation with 1ng/ml IL-1b. MMP-13 levels
in the conditioned media were measured using an MMP-13 Fluorokine
Assay (R&D Systems). Detection of endogenous antibodies in the joints
of rat, wild-type mice or mice expressing human immunoglobulins was
assessed by immunohistochemistry using secondary anti-rat, anti-mouse
or anti-human antibodies.
Results: In human primary chondrocyte cultures, both Kineret and 6F3
were potent inhibitors of IL-1 induced MMP-13 production. Whereas
Kineret retained its potency in cartilage explants, the potency of 6F3 was
dramatically diminished in cartilage explants, suggesting that the larger
molecule was impaired from reaching its target by the extracellular
matrix. To further address whether antibodies penetrate cartilage, the
detection of endogenous antibodies in the joints of rat, wild-type
mice or mice expressing human immunoglobulins was assessed by
immunohistochemistry using secondary anti-rat, anti-mouse or anti-
human antibodies. Endogenous rat, mouse or human antibodies were
not present in either articular or growth plate cartilage. In contrast,
saturating levels of endogenous antibody was detected in the adjacent
ﬁbrocartilage and soft tissues including the synovium, ligaments, the
joint capsule and stroma surrounding bone marrow blood vessels.
Conclusions: Collectively, these data demonstrate that antibodies do
not normally penetrate either articular or growth plate cartilage. As
such, antibodies do not represent a viable therapeutic modality for
targeting chondrocyte-mediated processes. Smaller alternatives such as
Fab′ fragments and non-antibody scaffolds may offer advantages over
antibodies for achieving cartilage penetration.
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Purpose: Previous studies have shown that co-culture of primary
chondrocytes with various sources of multipotent cells results in a higher
relative amount of cartilage matrix formation than cultures containing
only chondrocytes. The aim of this study is to investigate the mechanism
underlying this observation.
Methods: Cell culture: Human primary chondrocytes (PC) were isolated
from cartilage biopsies of patients undergoing total knee replacement
after collagenase II digestion. Human mesenchymal stem cells were
isolated from bone marrow aspirates. The use of all human biopsies
in this study was approved by a local Medical Ethical Committee.
Histology: Cell pellets were ﬁxed and embedded in parafﬁn
using routine procedures. Sections were cut and stained for
sulfated glycosaminoglycans (GAG) with alcian blue combined with
counterstaining of nuclear fast red.
GAG and DNA assay: Cell pellets were were digested with proteinase K to
release GAGs. Then GAG content was spectrophotometrically determined
with 1,9-dimethylmethylene blue chloride using an ELISA reader. Cell
number was determined by quantiﬁcation of total DNA using a CyQuant
DNA Kit.
EdU staining and quantiﬁcation: EdU (5-ethynyl-2′-deoxyuridine) was
added to the culture media to label proliferating cells. Pellets were
cryosectioned and stained for EdU with Click-iT® EdU Imaging Kit.
Nuclei were counterstained with Hoechst 33342. Images were taken
and analyzed with ImageJ.
Short Tandem Repeats (STR) analysis. STR analyses of genomic DNA
samples were performed with PowerPlex 16 System. The amount of
DNA present for each donor was calculated from the areas of the
electropherogram for each locus of MSCs’ or PCs’ speciﬁc alleles and
the ratio of MSCs and PCs was determined.
Results: Cocultures increase GAG formation. Histology and GAG
quantiﬁcation were performed to evaluate cartilage formation. Alcian
blue staining indicated the presence of GAG in all experimental
groups. In the positively stained areas, cells showed typical chondrocyte
morphology and embedding in lacunae. GAG quantiﬁcation showed a
trend of increasing total GAG with increasing initial percentage of PC.
When total GAG content was normalized to the initial percentage of
PC, co-culture pellets showed signiﬁcantly higher GAG content than
monocultures.
Cocultures increase chondrocytes proliferation. Cell proliferation was
then examined by using EdU incorporation. PCs were labeled with CM-
DiI to distinguish them from MSCs. At day 2, EdU positive cells were
predominantly found at the periphery of the pellets where red labeled
PCs resided. The percentage of EdU positive MSCs or PC was determined.
PCs in cocultures proliferate at higher rate than PC in monocutlure.
Ratio of MSCs decreases after coculture. To determine the ratio of MSC
and PC after coculture STR loci in different donors were analyzed. The
results indicated that the proportion of MSCs decreased signiﬁcantly
after 4 weeks cocultures.
Conclusions: In pellet cocultures, MSC act as trophic mediators
stimulating cartilage matrix formation by promoting proliferation of
primary chondrocytes rather than differentiating into chondrocytes.
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Purpose: Osteoarthritis (OA) and Rheumatoid Arthrisis (RA) are
characterized by degradation of the cartilage. Proteases of the coagulation
cascade and the ﬁbrinolytic system are elevated in both plasma and
synovial ﬂuid of OA and RA patients. Cross-talking between coagulation
and inﬂammation is mediated by protease-activated-receptors (PARs),
a cell membrane receptor family. These receptors are transmembrane
G protein-coupled receptors that are activated through cleavage by
serine proteases, such as thrombin and plasmin. PARs are expressed at
increased levels in human OA and RA synovium and cartilage. Activation
of these PARs results in the induction of catabolic and proinﬂammatory
pathways. Our aim was to study whether thrombin, plasmin and PAR
agonists induce cartilage damage in human healthy and OA cartilage.
Furthermore, we wanted to investigate if thrombin and plasmin induce
cartilage damage in a PAR-dependent manner.
Methods: Healthy full-thickness human articular cartilage tissue was
obtained postmortem within 24 hours after death of the donor. Full-
thickness OA human articular cartilage tissue was obtained during
total knee surgery. Slices of cartilage were cut aseptically from the
articular surface and kept in phosphate-buffered saline. Within 1 hour
of dissection the slices were cut into square pieces, weighed aseptically
(range, 5.0 to 15.0mg) and each sample was individually put into culture.
Cartilage was pre-cultured for two days in medium supplemented
with serum. Subsequently, the cartilage was cultured in serum-free
medium. After 24h the serum-free medium was refreshed and cartilage
was cultured for 4 days in serum-free medium in the presence of
different concentrations thrombin (10, 30 or 100nM), plasmin (1, 3, 10,
30 or 100nM), PAR1 agonist TFLLR-NH2(100mM), PAR2 agonist SLIGKV
(100mM), with or without co-culture with PAR1 antagonist SCH79797
(100mM) or PAR2 antagonist FSLLRY-NH2 (100mM). Cartilage matrix
turnover, in terms of proteoglycan synthesis, -release, and -content, was
determined at day 4.
Results: Thrombin and plasmin increased proteoglycan release in both
healthy cartilage and osteoarthritis cartilage in a dose-dependent manner
(471% for thrombin at 100nM; 744% for plasmin at 100nM; both
p < 0.05). Proteoglycan synthesis and content were not signiﬁcantly
changed by thrombin or plasmin. Thrombin-induced and plasmin-
induced proteoglycan release were not affected by co-culture with either
PAR1 antagonist SCH79797, or PAR2 antagonist FSLLRY-NH2. Also the
direct stimulation with PAR1 agonist TFLLR-NH2, or PAR2 agonist SLIGKV
failed to induce proteoglycan release.
